Emcure Pharmaceuticals Ltd vs Sat Kartar Shopping Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 09, 2026

Key Highlights

The Latest Trading Price of Emcure Pharmaceuticals Ltd is ₹ 1641 as of 08 May 15:30 . The P/E Ratio of Emcure Pharmaceuticals Ltd changed from 29.8 on March 2025 to 29.8 on March 2025 . This represents a CAGR of 0.00% over 1 yearsThe P/E Ratio of Sat Kartar Shopping Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of Emcure Pharmaceuticals Ltd changed from ₹ 20327 crore on March 2025 to ₹ 20327 crore on March 2025 . This represents a CAGR of 0.00% over 1 yearsThe Market Cap of Sat Kartar Shopping Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 years The revenue of Emcure Pharmaceuticals Ltd for the Mar '26 is ₹ 2484 crore as compare to the Dec '25 revenue of ₹ 2365 crore. This represent the growth of 5.02% The revenue of Sat Kartar Shopping Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Emcure Pharmaceuticals Ltd for the Mar '26 is ₹ 493.84 crore as compare to the Dec '25 ebitda of ₹ 456.45 crore. This represent the growth of 8.19% The ebitda of Sat Kartar Shopping Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Emcure Pharmaceuticals Ltd changed from ₹ 152.59 crore to ₹ 243.74 crore over 8 quarters. This represents a CAGR of 26.39% The net profit of Sat Kartar Shopping Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% The Dividend Payout of Emcure Pharmaceuticals Ltd changed from 4.3 % on March 2021 to 17.92 % on March 2025 . This represents a CAGR of 33.04% over 5 yearsThe Dividend Payout of Sat Kartar Shopping Ltd changed from 3.11 % on March 2024 to 11.22 % on March 2025 . This represents a CAGR of 89.94% over 2 years .

About Emcure Pharmaceuticals Ltd

Emcure Pharmaceuticals Limited was originally incorporated as Emcure Pharmaceuticals Private Limited', as a Private Company, pursuant to a Certificate of Incorporation dated April 16, 1981 issued by Registrar of Companies, Maharashtra at Bombay.
Subsequently, Company was converted into a Public Company and the name of Company was changed to Emcure Pharmaceuticals Limited', through a fresh Certificate of Incorporation issued by the RoC, Maharashtra in Pune on September 18, 2001. Emcure Pharmaceuticals an Indian pharmaceutical company engaged in developing, manufacturing and globally marketing a broad range of pharmaceutical products across several major therapeutic areas.
In India, they are present across acute and chronic therapeutic areas, and their key therapeutic areas include gynecology, cardiovascular, vitamins, minerals and nutrients, human immunodeficiency virus antivirals, blood-related and oncology/anti-neoplastics.

About Sat Kartar Shopping Ltd

Sat Kartar Shopping Limited was incorporated as a Private Limited Company with the name of 'Sat Kartar Shopping Private Limited' vide Certificate of Incorporation dated June 29, 2012, issued by Registrar of Companies, Delhi.
Further, Company converted into a Public Limited Company & name of the Company was changed to Sat Kartar Shopping Limited & Registrar of Companies, Delhi has issued a New Certificate of Incorporation consequent upon conversion dated July 12, 2021.
Manprit Singh Chadha is the Promoter of the Company. Sat Kartar Shopping is an Ayurveda healthcare company committed to providing natural wellness solutions relating to specific therapeutic areas and general lifestyle products, committed to promote a healthier lifestyle.
It integrate traditional Ayurvedic knowledge with modern research to empower individuals to adopt healthier lifestyles.

FAQs for the comparison of Emcure Pharmaceuticals Ltd and Sat Kartar Shopping Ltd

Which company has a larger market capitalization, Emcure Pharmaceuticals Ltd or Sat Kartar Shopping Ltd?

Market cap of Emcure Pharmaceuticals Ltd is 31,123 Cr while Market cap of Sat Kartar Shopping Ltd is 316 Cr

What are the key factors driving the stock performance of Emcure Pharmaceuticals Ltd and Sat Kartar Shopping Ltd?

The stock performance of Emcure Pharmaceuticals Ltd and Sat Kartar Shopping Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Emcure Pharmaceuticals Ltd and Sat Kartar Shopping Ltd?

As of May 9, 2026, the Emcure Pharmaceuticals Ltd stock price is INR ₹1641.6. On the other hand, Sat Kartar Shopping Ltd stock price is INR ₹201.15.

How do dividend payouts of Emcure Pharmaceuticals Ltd and Sat Kartar Shopping Ltd compare?

To compare the dividend payouts of Emcure Pharmaceuticals Ltd and Sat Kartar Shopping Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.